JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

A8172 Dihydroeponemycin

1 Citation

Summary: Proteasome inhibitor,antitumor reagent,eponemycin ddrivative

≥15.6 mg/mL
A2585 MG-132

26 Citation

Target: Proteasome

Summary: Proteasome inhibitor, Cell permeable, reversible

≥23.78 mg/mL
A8487 Nocodazole

1 Citation

Target: Microtubules/Tubulins

Summary: Tubulin production inhibitor,anti-neoplastic agent

insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
B6032 CB-5083

Target: p97

Summary: p97 inhibitor

insoluble in H2O; ≥20.65 mg/mL
B6179 VPS34-IN1

Summary: Vps34 inhibitor

Soluble in DMSO
A8740 C598-0466

Summary: USP7 inhibitor

≥40.2 mg/mL
A8715 SBI-0206965

2 Citation

Target: ULK1

Summary: ULK1 inhibitor

≥24.47 mg/mL
B6026 VR23

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
B7745 SZL P1-41

Summary: Skp2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥5.03 mg/mL
A3966 Doxorubicin

3 Citation

Summary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic

≥27.2 mg/mL